9 Things Buyers Check Before Acquiring a Ketamine Clinic
Buyers are circling interventional psychiatry again. Pharma has paid billions for psychedelic developers, Spravato has proven that insurance rails exist, and the first wave of ketamine roll ups left behind lessons the next wave is using. When a buyer looks at a clinic, the review is unglamorous. Here are nine things they check, and what each one looks like when it goes well.
Confidential
We have access to ketamine clinic buyers.
Interested in selling your practice, or bringing on an investment partner? Tell us about your practice. It takes about two minutes, with nothing to look up and no financial statements.
Nothing you enter is shared with anyone unless you tell us to on the last page. HealingMaps makes introductions only and charges no fee.
| What Buyers Check | What Good Looks Like |
|---|---|
| Books | Accrual basis financials with a profit and loss statement per location |
| Revenue mix | Payer and Spravato revenue alongside cash pay, not cash pay alone |
| Compliance file | Current DEA and state registrations, consent forms, adverse event logs |
| Outcomes | Standardized scores in a system that can state a response rate |
| Key person risk | Written protocols and a second provider who can run the schedule |
| Patient pipeline | Referral relationships and organic demand, not only paid ads |
| Licenses | Registrations and medical directorships that survive a change of owner |
| Payer contracts | Contracts held in a way that can transfer, which usually means a group NPI |
| Capacity | Chair and room utilization a buyer can model and expand |
1. The Books
Cash basis bookkeeping is normal in owner operated clinics. It is also the first thing that slows a deal.
Buyers want accrual financials and a profit and loss statement for each location. Personal expenses run through the business get found, and every one of them costs trust.
This is fixable, but not quickly. Converting a few years of records takes an accountant and time a live deal rarely allows.
2. Revenue Mix
Where the money comes from changes how a buyer values it. Payer revenue and Spravato read as durable healthcare income. Pure cash pay reads as consumer spending.
Spravato has made that case hard to argue with, growing to well over half a billion dollars a quarter. Clinics with billing infrastructure look like healthcare companies to a buyer.
Cash pay is not a flaw. It simply gets valued differently, and our analysis of posted prices shows how much that market varies by state.
3. The Compliance File
This is the fastest deal killer, because problems here are not negotiable. A buyer’s lawyer reads DEA registration, state registrations, consent documentation and adverse event logs line by line.
The standard is boring and absolute. Records current, complete, and organized well enough that someone outside the practice can follow them.
Deadlines matter here too. A clinic prescribing by telehealth should know where it stands on the DEA telehealth rules and the other dates on the regulatory calendar.
4. Documented Outcomes
Buyers increasingly ask what a clinic can prove about its results. A response rate drawn from stored scores is an asset. Testimonials are not.
The reason is commercial. Documented response rates across thousands of treatments are something a buyer can take to payers and partners, and no single clinic can assemble them quickly.
This is the item that cannot be fixed during a deal, because the data has to have been collected all along. We made the full case in our piece on what outcomes data is worth.
5. Key Person Risk
If protocols live in the owner’s head and referral relationships live in the owner’s phone, a buyer is purchasing a job rather than a business.
Delegation agreements, written protocols and cross trained staff convert personal expertise into something transferable. A second provider who can run the schedule is worth more than most marketing spend.
Buyers price this directly. It usually shows up as a longer required employment agreement or a larger portion of the price held back.
6. The Patient Pipeline
A buyer wants demand that survives the transition. Referral relationships and organic search hold value. Paid advertising stops producing the day it stops running.
Referrals also depend on the previous item. Relationships that belong to the practice transfer. Relationships that belong to one clinician often walk out with that clinician.
7. Licenses That Travel
This is where the first roll up wave broke. Licensing, staffing rules and medical directorships do not cross state lines, and buyers underestimated how much local work each location required.
The chains that collapsed in 2023 assumed scale would solve it. We covered that history and what changed in our look at the next wave of consolidation.
States that formalize registration make this worse for new entrants and better for compliant operators. A scarce license is an asset.
8. Whether the Payer Contracts Can Move
This is the item owners raise least and buyers care about a lot. Insurance revenue only holds value if the contracts survive the sale.
Contracts credentialed under an individual provider rather than a group can end when that provider leaves. A clinic with payer revenue tied to one person may be selling something the buyer cannot keep.
It is worth confirming how each contract is held before a buyer asks. The answer shapes what the insurance line in the financials is actually worth.
9. Capacity
A buyer is modeling growth, which means chairs, rooms and hours. Utilization shows whether there is room to grow without a build out.
Session length drives this, and it is about to matter more. If longer psychedelic sessions arrive at interventional psychiatry sites, chair time economics change, and Spravato clinics are first in line.
Why This Is Worth Doing Before Anyone Calls
Pharma interest has been unmistakable, including the largest psychedelic acquisition yet. Clinic level buyers follow that money.
Every item on this list is either already true or takes months to make true. A clinic that starts after the first call is negotiating from behind.
Want to see where a practice stands? We built the 2026 Ketamine Practice Benchmark, a short confidential form that takes about two minutes. Every question is answerable from memory, with no paperwork to pull. It reports percentile benchmarks against peer practices rather than a dollar valuation.
Our full acquisition readiness guide covers the same ground with a checklist format for practices that want to work through it.
Patients looking for supervised care can start with our directory of verified ketamine clinics.
This article is for informational purposes and is not legal, tax or financial advice. Speak with counsel and an accountant before preparing a practice for sale.
